Board recommends Dividend
Marksans Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2015, inter alia, has recommended dividend of Rs. 0.12 (Rupees Zero and Paise Twelve) i.e. 12% per equity share of Re. 1/- each face value for the financial year ended March 31, 2015, subject to approval of the shareholders in the ensuing Annual General Meeting. Board to consider Dividend
Marksans Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 30, 2015, inter alia, to consider and approve Audited Financial Results of the Company for the financial year ended March 31, 2015 and to consider recommendation of dividend, if any, for the financial year ended March 31, 2015. Shareholding Pattern For March 31, 2015
Marksans Pharma Ltd has informed BSE about the Shareholding Pattern as on March 31, 2015. Outcome of Committee Meeting
Marksans Pharma Ltd has informed BSE that the Committee on Issue of Capital of the Company has at its meeting held March 30, 2015 issued and allotted 2,40,06,494 (Two crore forty lac six thousand four hundred and ninety four) Equity Shares of Re. 1/- each face value to the eligible qualified institutional buyers. Outcome of Committee Meeting
Marksans Pharma Ltd has submitted to BSE a copy of the resolution passed at the meeting of the Committee on Issue of Capital (the "Committee") of the Company held on March 27, 2015. Financial Results with Results Press Release & Limited Review for Dec 31, 2014 (Standalone)
Marksans Pharma Ltd has informed BSE that about the Standalone Financial Results, Results Press Release & a copy of the Limited Review Report for the period ended December 31, 2014 Shareholding Pattern For December 31, 2014
Marksans Pharma Ltd has informed BSE about the Shareholding Pattern as on December 31, 2014. Revised Shareholding Pattern For September 30, 2014
With reference to earlier announcement regarding Shareholding Pattern For September 30, 2014 dated October 14, 2014.Marksans Pharma Ltd has now submitted to BSE a Revised Shareholding Pattern For September 30, 2014. Financial Results with Results Press Release & Limited Review for Sept 30, 2014
Marksans Pharma Ltd has informed BSE about the Financial Results, Results Press Release & a copy of the Limited Review Report for the period ended September 30, 2014.